Literature DB >> 21317588

Integration of buprenorphine for substance-abuse treatment by HIV care providers.

Gerald Friedland1, David Vlahov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21317588     DOI： 10.1097/QAI.0b013e31820bc9ba

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  4 in total

Review 1.  A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice.

Authors:  R Douglas Bruce; David E Moody; Frederick L Altice; Marc N Gourevitch; Gerald H Friedland
Journal:  Expert Rev Clin Pharmacol       Date:  2013-05       Impact factor: 5.045

2.  The prevalence and patterns of substance use by birth cohort among HIV-positive adults in Florida.

Authors:  Zachary L Mannes; Vaughn E Bryant; Larry E Burrell; Huiyin Lu; Erin G Ferguson; Zhi Zhou; Robert L Cook; Nicole Ennis
Journal:  Aging Ment Health       Date:  2018-02-13       Impact factor: 3.658

Review 3.  Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review.

Authors:  P Todd Korthuis; Dennis McCarty; Melissa Weimer; Christina Bougatsos; Ian Blazina; Bernadette Zakher; Sara Grusing; Beth Devine; Roger Chou
Journal:  Ann Intern Med       Date:  2016-12-06       Impact factor: 25.391

4.  Editorial: HIV and Illicit Drugs of Abuse.

Authors:  Venkata S R Atluri
Journal:  Front Microbiol       Date:  2016-03-10       Impact factor: 5.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.